Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Study protocol

A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale

Authors: Vamadevan S Ajay, Maoyi Tian, Hao Chen, Yangfeng Wu, Xian Li, Danzeng Dunzhu, Mohammed K Ali, Nikhil Tandon, Anand Krishnan, Dorairaj Prabhakaran, Lijing L Yan

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

In resource-poor areas of China and India, the cardiovascular disease burden is high, but availability of and access to quality healthcare is limited. Establishing a management scheme that utilizes the local infrastructure and builds healthcare capacity is essential for cardiovascular disease prevention and management. The study aims to develop, implement, and evaluate the feasibility and effectiveness of a simplified, evidence-based cardiovascular management program delivered by community healthcare workers in resource-constrained areas in Tibet, China and Haryana, India.

Methods/design

This yearlong cluster-randomized controlled trial will be conducted in 20 villages in Tibet and 20 villages in Haryana. Randomization of villages to usual care or intervention will be stratified by country. High cardiovascular disease risk individuals (aged 40 years or older, history of heart disease, stroke, diabetes, or measured systolic blood pressure of 160 mmHg or higher) will be screened at baseline. Community health workers in the intervention villages will be trained to manage and follow up high-risk patients on a monthly basis following a simplified ‘2 + 2’ intervention model involving two lifestyle recommendations and the appropriate prescription of two medications. A customized electronic decision support system based on the intervention strategy will be developed to assist the community health workers with patient management. Baseline and follow-up surveys will be conducted in a standardized fashion in all villages. The primary outcome will be the net difference between-group in the proportion of high-risk patients taking antihypertensive medication pre- and post-intervention. Secondary outcomes will include the proportion of patients taking aspirin and changes in blood pressure. Process and economic evaluations will also be conducted.

Discussion

To our knowledge, this will be the first study to evaluate the effect of a simplified management program delivered by community health workers with the help of electronic decision support system on improving the health of high cardiovascular disease risk patients. If effective, this intervention strategy can serve as a model that can be implemented, where applicable, in rural China, India, and other resource-constrained areas.

Trial registration

The trial was registered in the clinicaltrials.gov database on 30 December, 2011 and the registration number is NCT01503814.
Literature
1.
go back to reference World Health Organization PHAoC: Preventing chronic diseases: a vital investment. 2005, Geneva; Ottawa: World Health Organization; Public Health Agency of Canada World Health Organization PHAoC: Preventing chronic diseases: a vital investment. 2005, Geneva; Ottawa: World Health Organization; Public Health Agency of Canada
2.
go back to reference Joshi R, Jan S, Wu Y, MacMahon S: Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol. 2008, 52 (23): 1817-1825. 10.1016/j.jacc.2008.08.049.CrossRefPubMed Joshi R, Jan S, Wu Y, MacMahon S: Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol. 2008, 52 (23): 1817-1825. 10.1016/j.jacc.2008.08.049.CrossRefPubMed
3.
go back to reference Reddy KS: Cardiovascular disease in non-Western countries. N Engl J Med. 2004, 350 (24): 2438-2440. 10.1056/NEJMp048024.CrossRefPubMed Reddy KS: Cardiovascular disease in non-Western countries. N Engl J Med. 2004, 350 (24): 2438-2440. 10.1056/NEJMp048024.CrossRefPubMed
4.
go back to reference Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104 (22): 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104 (22): 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed
5.
go back to reference Liu L: Cardiovascular diseases in China. Biochem Cell Biol. 2007, 85 (2): 157-163. 10.1139/O07-004.CrossRefPubMed Liu L: Cardiovascular diseases in China. Biochem Cell Biol. 2007, 85 (2): 157-163. 10.1139/O07-004.CrossRefPubMed
6.
go back to reference Mackay J, Mensah GA, Mendis S, Greenlund K: The Atlas of Heart Disease and Stroke. 2004, World Health Organization: Geneva Mackay J, Mensah GA, Mendis S, Greenlund K: The Atlas of Heart Disease and Stroke. 2004, World Health Organization: Geneva
7.
go back to reference Gusanglamu P, Cai YX, Rendan L: Hypertension prevalence, awareness, treatment and control rates in agricultural and pastoral areas in Tibet, China. Zhong Guo Yi Xue Zhi Nan. 2010, 8 (027): 79-81. Gusanglamu P, Cai YX, Rendan L: Hypertension prevalence, awareness, treatment and control rates in agricultural and pastoral areas in Tibet, China. Zhong Guo Yi Xue Zhi Nan. 2010, 8 (027): 79-81.
8.
go back to reference Zhao X, Li S, Ba S, He F, Li N, Ke L, Li X, Lam C, Yan LL, Zhou Y, Wu Y: Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Am J Hypertens. 2012, 25 (5): 583-589. 10.1038/ajh.2012.9.CrossRefPubMed Zhao X, Li S, Ba S, He F, Li N, Ke L, Li X, Lam C, Yan LL, Zhou Y, Wu Y: Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Am J Hypertens. 2012, 25 (5): 583-589. 10.1038/ajh.2012.9.CrossRefPubMed
9.
go back to reference Anand K, Shah B, Gupta V, Khaparde K, Pau E, Menon GR, Kapoor SK: Risk factors for non-communicable disease in urban Haryana: a study using the STEPS approach. Indian Heart J. 2008, 60 (1): 9-18.PubMed Anand K, Shah B, Gupta V, Khaparde K, Pau E, Menon GR, Kapoor SK: Risk factors for non-communicable disease in urban Haryana: a study using the STEPS approach. Indian Heart J. 2008, 60 (1): 9-18.PubMed
10.
go back to reference Anand K, Shah B, Yadav K, Singh R, Mathur P, Paul E, Kapoor SK: Are the urban poor vulnerable to non-communicable diseases? A survey of risk factors for non-communicable diseases in urban slums of Faridabad. Natl Med J India. 2007, 20 (3): 115-120.PubMed Anand K, Shah B, Yadav K, Singh R, Mathur P, Paul E, Kapoor SK: Are the urban poor vulnerable to non-communicable diseases? A survey of risk factors for non-communicable diseases in urban slums of Faridabad. Natl Med J India. 2007, 20 (3): 115-120.PubMed
11.
go back to reference Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X: Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008, 118 (25): 2679-2686. 10.1161/CIRCULATIONAHA.108.788166.CrossRefPubMed Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X: Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008, 118 (25): 2679-2686. 10.1161/CIRCULATIONAHA.108.788166.CrossRefPubMed
12.
go back to reference The Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke. Update. 2002, London: Royal College of Physicians The Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke. Update. 2002, London: Royal College of Physicians
13.
go back to reference Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA, American Heart Association Stroke Council CoC, Stroke Nursing CoCC, Council on Peripheral Vascular D: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014, 45 (7): 2160-2236. 10.1161/STR.0000000000000024.CrossRefPubMed Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA, American Heart Association Stroke Council CoC, Stroke Nursing CoCC, Council on Peripheral Vascular D: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014, 45 (7): 2160-2236. 10.1161/STR.0000000000000024.CrossRefPubMed
14.
go back to reference China guideline of hypertension updated 2005 Progression in the diagnosis and management of hypertension: China Hypertension League. 2005 China guideline of hypertension updated 2005 Progression in the diagnosis and management of hypertension: China Hypertension League. 2005
15.
go back to reference Beilin LJ: Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. J Hypertens Suppl. 1994, 12 (10): S71-S81.PubMed Beilin LJ: Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. J Hypertens Suppl. 1994, 12 (10): S71-S81.PubMed
16.
go back to reference Clark AM, Hartling L, Vandermeer B, McAlister FA: Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005, 143 (9): 659-672. 10.7326/0003-4819-143-9-200511010-00010.CrossRefPubMed Clark AM, Hartling L, Vandermeer B, McAlister FA: Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005, 143 (9): 659-672. 10.7326/0003-4819-143-9-200511010-00010.CrossRefPubMed
17.
go back to reference Cutler JA, Follmann D, Allender PS: Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997, 65 (2 Suppl): 643S-651S.PubMed Cutler JA, Follmann D, Allender PS: Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997, 65 (2 Suppl): 643S-651S.PubMed
18.
go back to reference Cutler JA, Follmann D, Elliott P, Suh I: An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991, 17 (1 Suppl): I27-I33.CrossRefPubMed Cutler JA, Follmann D, Elliott P, Suh I: An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991, 17 (1 Suppl): I27-I33.CrossRefPubMed
19.
go back to reference European Society of Hypertension-European Society of Cardiology Guidelines C: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21 (6): 1011-1053.CrossRef European Society of Hypertension-European Society of Cardiology Guidelines C: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21 (6): 1011-1053.CrossRef
21.
go back to reference Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Potter JF, Sever PS, Mc GTS, British Hypertension S: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004, 18 (3): 139-185. 10.1038/sj.jhh.1001683.CrossRefPubMed Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Potter JF, Sever PS, Mc GTS, British Hypertension S: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004, 18 (3): 139-185. 10.1038/sj.jhh.1001683.CrossRefPubMed
22.
go back to reference National Vascular Disease Prevention Alliance: Guidelines for the Assessment of Absolute Cardiovascualr Disease Risk. 2009, Melbourne: National Heart Foundation of Australia National Vascular Disease Prevention Alliance: Guidelines for the Assessment of Absolute Cardiovascualr Disease Risk. 2009, Melbourne: National Heart Foundation of Australia
23.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560. doi:10.1001/jama.289.19.2560. PubMed PMID: 12748199CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560. doi:10.1001/jama.289.19.2560. PubMed PMID: 12748199CrossRefPubMed
24.
go back to reference Gaziano TA, Opie LH, Weinstein MC: Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006, 368 (9536): 679-686. 10.1016/S0140-6736(06)69252-0.CrossRefPubMedPubMedCentral Gaziano TA, Opie LH, Weinstein MC: Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006, 368 (9536): 679-686. 10.1016/S0140-6736(06)69252-0.CrossRefPubMedPubMedCentral
25.
go back to reference Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH: Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005, 112 (23): 3569-3576. 10.1161/CIRCULATIONAHA.105.535922.CrossRefPubMed Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH: Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005, 112 (23): 3569-3576. 10.1161/CIRCULATIONAHA.105.535922.CrossRefPubMed
26.
go back to reference Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB: Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003, 361 (9359): 717-725. 10.1016/S0140-6736(03)12655-4.CrossRefPubMed Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB: Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003, 361 (9359): 717-725. 10.1016/S0140-6736(03)12655-4.CrossRefPubMed
27.
go back to reference Reddy KS: Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr. 2002, 5 (1A): 231-237.CrossRefPubMed Reddy KS: Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr. 2002, 5 (1A): 231-237.CrossRefPubMed
28.
go back to reference Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K, Cardiovascular U-PCSo, Cardiopulmonary Epidemiology Research G, China Multicenter Collaborative Study of Cardiovascular Epidemiology Research G: Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006, 114 (21): 2217-2225. 10.1161/CIRCULATIONAHA.105.607499.CrossRefPubMed Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K, Cardiovascular U-PCSo, Cardiopulmonary Epidemiology Research G, China Multicenter Collaborative Study of Cardiovascular Epidemiology Research G: Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006, 114 (21): 2217-2225. 10.1161/CIRCULATIONAHA.105.607499.CrossRefPubMed
29.
go back to reference Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B: Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh. India Am Heart J. 2009, 158 (3): 349-355. 10.1016/j.ahj.2009.05.034.CrossRefPubMed Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B: Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh. India Am Heart J. 2009, 158 (3): 349-355. 10.1016/j.ahj.2009.05.034.CrossRefPubMed
30.
go back to reference Joshi R, Chow CK, Raju PK, Raju KR, Gottumukkala AK, Reddy KS, Macmahon S, Heritier S, Li Q, Dandona R, Neal B: The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. J Am Coll Cardiol. 2012, 59 (13): 1188-1196. 10.1016/j.jacc.2011.10.901.CrossRefPubMed Joshi R, Chow CK, Raju PK, Raju KR, Gottumukkala AK, Reddy KS, Macmahon S, Heritier S, Li Q, Dandona R, Neal B: The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. J Am Coll Cardiol. 2012, 59 (13): 1188-1196. 10.1016/j.jacc.2011.10.901.CrossRefPubMed
31.
go back to reference Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y: Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014, 14: 345-10.1186/1471-2458-14-345.CrossRefPubMedPubMedCentral Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y: Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014, 14: 345-10.1186/1471-2458-14-345.CrossRefPubMedPubMedCentral
32.
go back to reference Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, West M, Barlow A, Lewis-Boyer L, Donnelly-Strozzo M, Curtis C, Anderson K: Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes. 2011, 4 (6): 595-602. 10.1161/CIRCOUTCOMES.111.961573.CrossRefPubMedPubMedCentral Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, West M, Barlow A, Lewis-Boyer L, Donnelly-Strozzo M, Curtis C, Anderson K: Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes. 2011, 4 (6): 595-602. 10.1161/CIRCOUTCOMES.111.961573.CrossRefPubMedPubMedCentral
33.
go back to reference Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, Varghese M, Thara R, Weiss HA, Williams P, McCrone P, Patel V, Thornicroft G: Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Lancet. 2014, 383 (9926): 1385-1394. 10.1016/S0140-6736(13)62629-X.CrossRefPubMedPubMedCentral Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, Varghese M, Thara R, Weiss HA, Williams P, McCrone P, Patel V, Thornicroft G: Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Lancet. 2014, 383 (9926): 1385-1394. 10.1016/S0140-6736(13)62629-X.CrossRefPubMedPubMedCentral
34.
go back to reference Dye CJ, Williams JE, Evatt JH: Health promotion practice. Improving Hypertension Self-Management With Community Health Coaches. 2014 Dye CJ, Williams JE, Evatt JH: Health promotion practice. Improving Hypertension Self-Management With Community Health Coaches. 2014
35.
go back to reference Ursua RA, Aguilar DE, Wyatt LC, Katigbak C, Islam NS, Tandon SD, Nur PR, Van Devanter N, Rey MJ, Trinh-Shevrin C: A community health worker intervention to improve management of hypertension among Filipino Americans in New York and New Jersey: a pilot study. Ethn Dis. 2014, 24 (1): 67-76.PubMedPubMedCentral Ursua RA, Aguilar DE, Wyatt LC, Katigbak C, Islam NS, Tandon SD, Nur PR, Van Devanter N, Rey MJ, Trinh-Shevrin C: A community health worker intervention to improve management of hypertension among Filipino Americans in New York and New Jersey: a pilot study. Ethn Dis. 2014, 24 (1): 67-76.PubMedPubMedCentral
36.
go back to reference Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N, Hypertension Research G: Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med. 2009, 151 (9): 593-601. 10.7326/0003-4819-151-9-200911030-00004.CrossRefPubMed Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N, Hypertension Research G: Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med. 2009, 151 (9): 593-601. 10.7326/0003-4819-151-9-200911030-00004.CrossRefPubMed
37.
go back to reference Surka S, Edirippulige S, Steyn K, Gaziano T, Puoane T, Levitt N: Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers. Int J Med Inform. 2014, 83 (9): 648-654. 10.1016/j.ijmedinf.2014.06.008.CrossRefPubMedPubMedCentral Surka S, Edirippulige S, Steyn K, Gaziano T, Puoane T, Levitt N: Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers. Int J Med Inform. 2014, 83 (9): 648-654. 10.1016/j.ijmedinf.2014.06.008.CrossRefPubMedPubMedCentral
38.
go back to reference Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A, Rubinstein A: The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E-health: Offic J Am Telemed Assoc. 2014, 20 (1): 75-82.CrossRef Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A, Rubinstein A: The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E-health: Offic J Am Telemed Assoc. 2014, 20 (1): 75-82.CrossRef
39.
go back to reference Meade TW, Wald N, Collins R: CONSORT statement on the reporting standards in clinical trials. Recommendations are inappropriate for trial reports. BMJ. 1997, 314 (7087): 1126-10.1136/bmj.314.7087.1126.CrossRefPubMedPubMedCentral Meade TW, Wald N, Collins R: CONSORT statement on the reporting standards in clinical trials. Recommendations are inappropriate for trial reports. BMJ. 1997, 314 (7087): 1126-10.1136/bmj.314.7087.1126.CrossRefPubMedPubMedCentral
40.
go back to reference Liu L: Chinese national hypertension prevention guideline 2010. Lisheng Liu. 2011, 19 (8): 701-708. Liu L: Chinese national hypertension prevention guideline 2010. Lisheng Liu. 2011, 19 (8): 701-708.
41.
go back to reference Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E: 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013, 29 (2): 151-167. 10.1016/j.cjca.2012.11.032.CrossRefPubMed Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E: 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013, 29 (2): 151-167. 10.1016/j.cjca.2012.11.032.CrossRefPubMed
42.
go back to reference Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129 (25 Suppl 2): S49-S73.CrossRefPubMed Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 129 (25 Suppl 2): S49-S73.CrossRefPubMed
43.
go back to reference Gupta R, Deedwania P: Interventions for cardiovascular disease prevention. Cardiol Clin. 2011, 29 (1): 15-34. 10.1016/j.ccl.2010.10.005.CrossRefPubMed Gupta R, Deedwania P: Interventions for cardiovascular disease prevention. Cardiol Clin. 2011, 29 (1): 15-34. 10.1016/j.ccl.2010.10.005.CrossRefPubMed
44.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation: European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012, 19 (4): 403-488. 10.1007/s12529-012-9242-5.CrossRefPubMed Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation: European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012, 19 (4): 403-488. 10.1007/s12529-012-9242-5.CrossRefPubMed
45.
go back to reference Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T, Niessen L, Franco OH: Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health. 2013, 13: 285-10.1186/1471-2458-13-285.CrossRefPubMedPubMedCentral Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T, Niessen L, Franco OH: Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health. 2013, 13: 285-10.1186/1471-2458-13-285.CrossRefPubMedPubMedCentral
46.
go back to reference Tang L, Patao C, Chuang J, Wong ND: Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007–2010). Am J Cardiol. 2013, 112 (8): 1126-1132. 10.1016/j.amjcard.2013.05.064.CrossRefPubMed Tang L, Patao C, Chuang J, Wong ND: Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007–2010). Am J Cardiol. 2013, 112 (8): 1126-1132. 10.1016/j.amjcard.2013.05.064.CrossRefPubMed
47.
go back to reference Parker DR, Evangelou E, Eaton CB: Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemp Clin Trials. 2005, 26 (2): 260-267. 10.1016/j.cct.2005.01.002.CrossRefPubMed Parker DR, Evangelou E, Eaton CB: Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemp Clin Trials. 2005, 26 (2): 260-267. 10.1016/j.cct.2005.01.002.CrossRefPubMed
50.
go back to reference Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005, 330 (7494): 765-10.1136/bmj.38398.500764.8F.CrossRefPubMedPubMedCentral Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005, 330 (7494): 765-10.1136/bmj.38398.500764.8F.CrossRefPubMedPubMedCentral
Metadata
Title
A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale
Authors
Vamadevan S Ajay
Maoyi Tian
Hao Chen
Yangfeng Wu
Xian Li
Danzeng Dunzhu
Mohammed K Ali
Nikhil Tandon
Anand Krishnan
Dorairaj Prabhakaran
Lijing L Yan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-924

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue